参考文献/References:
[1] Ozülker T,Kücüköz Uzun A,Oztllker F,et al.Comparison of 88F-FDG-PET/CT with 99mTc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.Nucl Med Commun,2010,31(6):597-603.
[2] Liu T,Cheng T,Xu W.A meta-analysis of 88FDG-PET,MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer[J/OL].Skeletal Radiol,2010[2010-05-22].http://www.springerlink,com/content/b400915kn767k582/fulhext,pdf.
[3] Messiou C,Cook G,deSouza NM.Imaging metastatic bone disease from carcinoma of the prostate.Br J Cancer.2009,101(8):1225-1232.
[4] Bury T,Barreto A,Daenen F,et ah Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.Eur J Nucl Med,1998,25(9):1244-1247.
[5] Cheran SK,Herndon JE 2nd,Patz EF Jr.Comparison of wholebody FDG-PET to bone scan for detection of bone melastases in patients with a new diagnosis of lung cancer.Lung Cancer,2004,44(3):317-325.
[6] Stefan K,Andreas K,Buck Felix M,et al.Detection of bone metastases in patients with lung cancer 99mTc-MDP planar bone scintigraphy,88F-fluoride PET or 88F-FDG PET/CT.Eur J Nucl Med Mol Imaging,2009,36(11):1807-1812.
[7] Marom EM,McAdams HP,Erasnms J,et al.Staging non-small cell lung cancer with whole-body PET.Radiology,1999,212(3):803-809.
[8] Buck AK,Herrmann K,Stargardt T,et al.Economic evaluation of PET and PET/CT in Oncology:evidence and methodologic approaches.J Nucl Med Technol,2010,38(1):6-17.
[9] Cook GJ.Skeletal metastases:what is the future role for nuclear medicine?.Eur J Nucl Med Mol hnaging,2009,36(11):1807-1812.
[10] Ito S,Kato K,Ikeda M,et al.Comparison of 88F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid eaneer.J Nucl Med,2007,48(6):889-895.
[11] Hamaoka T,Madewell JE,Podoloff DA,et al.Bone imagingingmetastatic breast cancer.J Clin Oncol,2004,22(14):2942-2953.
[12] Goya M,Ishii G,Miyamoto S,et al.Prostate-specific antigen induces apoptosis of osteoclast precursors:potential role in osteoblastie bone metastases of prostate cancer.Prostate,2006,66(15):1573-1584.
[13] Mundy GR.Metastasis to bone:causes,consequences and thera-peutic opportunities.Nat Rev Cancer,2002,2(8):584-593.
[14] Uematsu T,Yuen S,Yukisawa S.et al.Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.AJR Am J Roentgenol,2005,184(4):1266-1273.
[15] Ohla M,Tokuda Y,Suzuki Y evaluation of bony metastases et al.Whole body PET for the in patients with breast cancer:comparisnn with 99mTc-MDP bone scintigraphy.Nucl Med Comnmn 2001,22(8):875-879.
[16] Schin’meister H,Guhlmann A,Eisner K,et al.Sensitivity in detecting osseous lesions depends on anatomic localization:planar bone scintigraphy versus tSF PET.J Nucl Med,1999,40(10):1623-1629.
[17] Metser U,Lerman H,Blank A,et al.Malignant involvement of the spine:assessment by 88F-FDG PET/CT.J Nucl Med,2004,45(2):279-284.
[18] Nakai T,Okuyama C,Kubota T,et al.Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.EurJ Nucl Med Mol Imaging,2005,32(11):1253-1258.
相似文献/References:
[1]任越,张慧芳,胡波,等.电离辐射诱导小鼠骨电子顺磁共振信号检测的影响因素[J].国际放射医学核医学杂志,2015,39(5):371.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 004]
ren yue,zhang huifang,hu bo,et al.influencing factors of detection on ionizing radiation-induced electron paramagnetic resonance signal in bones[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):371.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 004]
[2]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[3]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
[4]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[5]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[6]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[7]高平,王茜,赵赟赟,等.99Tcm-MDP SPECT/CT显像用于骨肉瘤肺转移的诊断[J].国际放射医学核医学杂志,2014,38(3):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
Gao Ping,Wang Qian,Zhao Yunyun,et al.99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
[8]凌彩霞,肖国有.SPECT/CT骨断层显像及在恶性肿瘤骨转移诊断中的临床价值[J].国际放射医学核医学杂志,2014,38(4):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
Ling Caixia,Xiao Guoyou.The clinical value of SPECT/CT bone tomography in the diagnosis of malignant tumor metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
[9]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[10]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[11]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[12]徐海青,段俊,吴边.全身骨显像诊断前列腺癌骨转移与PSA水平及病理分级的相关性研究[J].国际放射医学核医学杂志,2011,35(1):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
XU Hai-qing,DUAN Jun,WU Bian.Study of relationship between the bone imaging, level of PSA and pathology grade in diagnosis of prostate carcinoma bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]